Burdette JE - Search Results

1

In vivo tumor growth of high-grade serous ovarian cancer cell lines.

Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J, Lantvit DD, Cardenas H, Fang F, Liu Y, Loughran E, Yang J, Sharon Stack M, Emerson RE, Cowden Dahl KD, V Barbolina M, Nephew KP, Matei D, Burdette JE. Mitra AK, et al. Among authors: burdette je. Gynecol Oncol. 2015 Aug;138(2):372-7. doi: 10.1016/j.ygyno.2015.05.040. Epub 2015 Jun 5. Gynecol Oncol. 2015. PMID: 26050922 Free PMC article.

2

Three-dimensional ovarian organ culture as a tool to study normal ovarian surface epithelial wound repair.

Jackson KS, Inoue K, Davis DA, Hilliard TS, Burdette JE. Jackson KS, et al. Among authors: burdette je. Endocrinology. 2009 Aug;150(8):3921-6. doi: 10.1210/en.2008-1674. Epub 2009 May 7. Endocrinology. 2009. PMID: 19423762 Free PMC article.

3

The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.

King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, Burdette JE. King SM, et al. Among authors: burdette je. Endocr Relat Cancer. 2011 Sep 20;18(5):627-42. doi: 10.1530/ERC-11-0107. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 21813729 Free PMC article.

4

The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation.

Kim M, Rooper L, Xie J, Rayahin J, Burdette JE, Kajdacsy-Balla AA, Barbolina MV. Kim M, et al. Among authors: burdette je. Mol Cancer Res. 2012 Nov;10(11):1419-29. doi: 10.1158/1541-7786.MCR-12-0361. Epub 2012 Sep 10. Mol Cancer Res. 2012. PMID: 22964431

5

Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas.

Quartuccio SM, Lantvit DD, Bosland MC, Burdette JE. Quartuccio SM, et al. Among authors: burdette je. PLoS One. 2013 May 31;8(5):e65067. doi: 10.1371/journal.pone.0065067. Print 2013. PLoS One. 2013. PMID: 23741457 Free PMC article.

6

Epithelial ovarian cancer experimental models.

Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP, Hales DB, Stack MS. Lengyel E, et al. Among authors: burdette je. Oncogene. 2014 Jul 10;33(28):3619-33. doi: 10.1038/onc.2013.321. Epub 2013 Aug 12. Oncogene. 2014. PMID: 23934194 Free PMC article. Review.

7

Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.

Modi DA, Sunoqrot S, Bugno J, Lantvit DD, Hong S, Burdette JE. Modi DA, et al. Among authors: burdette je. Nanoscale. 2014 Mar 7;6(5):2812-20. doi: 10.1039/c3nr05042d. Epub 2014 Jan 27. Nanoscale. 2014. PMID: 24468839

8

Mutation or loss of p53 differentially modifies TGFβ action in ovarian cancer.

Ó hAinmhire E, Quartuccio SM, Cheng W, Ahmed RA, King SM, Burdette JE. Ó hAinmhire E, et al. Among authors: burdette je. PLoS One. 2014 Feb 20;9(2):e89553. doi: 10.1371/journal.pone.0089553. eCollection 2014. PLoS One. 2014. PMID: 24586866 Free PMC article.

9

Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles.

Sunoqrot S, Bugno J, Lantvit D, Burdette JE, Hong S. Sunoqrot S, et al. Among authors: burdette je. J Control Release. 2014 Oct 10;191:115-22. doi: 10.1016/j.jconrel.2014.05.006. Epub 2014 May 14. J Control Release. 2014. PMID: 24837188 Free PMC article.

10

Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.

Desjardins M, Xie J, Gurler H, Muralidhar GG, Sacks JD, Burdette JE, Barbolina MV. Desjardins M, et al. Among authors: burdette je. J Ovarian Res. 2014 Jun 26;7:70. doi: 10.1186/1757-2215-7-70. eCollection 2014. J Ovarian Res. 2014. PMID: 24999371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page